(CIRB) A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

RTOG-0848
NCT01013649
Cancer - Pancreas
Tara Seery
Open
Treatment
Erlotinib, Gemcitabine, Gemzar, OSI-774, Tarceva
Chemotherapy multiple agents systemic, Chemotherapy single agent systemic
III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.